Seed funding lists can mix newly announced rounds with lifetime funding totals, extensions, or undated database entries. This is a small historical selection of 2024 seed announcements that can be traced to a statement by the company or an investor. It is not a comprehensive database, a live assessment of the companies, or investment advice. The amounts below describe what was announced at the time; they do not verify later revenue, product performance, or returns.
Four documented seed announcements
01
Persana AI — $2.3 million
On October 29, 2024, Persana's founders announced $2.3 million in seed backing alongside the launch of their sales-intelligence product. The company named Y Combinator, Race Capital, Stage 2 Capital, and individual backers. The announcement describes a funding round and a product plan; it is not independent evidence that the product improved customers' sales results.
02
Infinite Machine — $9.3 million
Infinite Machine announced the close of a $9.3 million seed round on October 29, 2024, led by Andreessen Horowitz's American Dynamism fund. It said the capital would support production and launch of its P1 electric scooter. A planned launch is different from verified delivery volume or commercial success.
03
Archon Biosciences — $20 million
Archon announced its emergence from stealth on October 30, 2024, with $20 million in seed financing led by Madrona Ventures. The company described computationally designed antibody-cage research. The financing and research direction are documented; no clinical efficacy or regulatory approval follows from a seed announcement.
04
ContraForce — $3.25 million
In its October 31, 2024, company-issued release, ContraForce announced a $3.25 million seed round co-led by GALLOS and DataTribe. It separately said the round brought total investment to $5.25 million. The $5.25 million figure is cumulative, so it must not be reported as the new seed-round amount.
How to read a seed-round figure
A seed round is a financing label, not a uniform company-age or risk rating. Companies can use equity, convertible instruments, or other structures and may close a round in stages. The published number may be a newly closed amount, a final round total, or all funding to date. Check the precise wording before comparing companies.
The ContraForce release is a useful example: $3.25 million describes the October seed round while $5.25 million describes its stated total investment after that round. Adding both figures would count the same money twice. For Persana, the founders' post establishes a stated seed backing amount but does not disclose every financing term.
Selection and limitations
The original topic covered a broad range of sectors. These four examples retain that breadth across sales software, urban electric mobility, biotechnology, and security operations, but each has a dated primary announcement identifying the round and amount. We excluded entries for which we could not establish those facts clearly from an issuer or investor statement.
Announcement dates are not necessarily wire-transfer dates. Private-company reports are not audited funding registers, and confidential rounds never appear in public lists. The companies' descriptions of future uses of capital should be read as intentions as of 2024, not proof of subsequent milestones.
Use the list as a starting point
For your own research, save the source URL, announcement date, currency, round label, amount, lead backer, and whether the stated sum is new funding or cumulative funding. Revisit company and investor updates for later developments. A historical list can help identify what was publicly announced in one year, but cannot establish a present valuation or whether the investment was successful.
None of these examples is a recommendation to invest. Private startup investments can be illiquid and risky, and a financing headline alone gives too little information to judge a business. If a decision has financial consequences, seek current company disclosures and qualified advice rather than treating a dated roundup as due diligence.